EGFR and lung carcinoma: Ware et al. used multiple EGFR mutant lung cancer cell lines rendered EGFR TKI resistant to demonstrate that acquisition of a mesenchymal phenotype was associated with acquired addiction to an FGF2-FGFR1 autocrine loop [45].